Crossmark

Artemether Improves Aβ1-42-Induced Mitochondrial Dysfunction and Protects Against Blood–Brain Barrier Damage Through Activating the CAMKK2/AMPK/PGC1α Signaling Pathway

Crossref DOI link: https://doi.org/10.1007/s12035-025-05141-8

Published Online: 2025-06-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Cai, Jun

Liu, Yuxuan

Gong, Li

Deng, Shengfeng

Zheng, Wenhua

Li, Shuai
Funding

Funding for this research was provided by:

The National Natural Science Foundation of China (82201620)

The China Postdoctoral Science Foundation (2023M734024)
License Information

Text and Data Mining valid from 2025-06-10

Version of Record valid from 2025-06-10
More Information

Article History

Received: 13 March 2025

Accepted: 4 June 2025

First Online: 10 June 2025

Declarations

:

: All experimental procedures involving these animals were approved by the Animal Ethics Committee of the University of Macau (No. UMAEC—019—2020).

: The authors declare no competing interests.

Document is current

Any future updates will be listed below